Heart4Data: Workshop Data LinkageWednesday March 6th, 2024
Heart4Data: Open call for project proposals on data linkageDeadline for submission is April 1st 2024
DCVA Welcomes two New Partners
From the beginning of the new year, on January 1st 2024, the Dutch CardioVascular Alliance (DCVA) has welcomed two new partners on board. These recent collaborations reinforce the DCVA’s ambition to reduce the cardiovascular disease burden by 25% by 2030.
DCVA Annual Plan 2024
The high burden of cardiovascular disease is one of the biggest health challenges of the future. Every day, hundreds of people are suddenly affected by a cardiac arrest, stroke or other condition.
Transforming Cardiovascular Health: Technology for a Brighter Future
In a significant step towards future-proof cardiovascular healthcare in the Netherlands, the Dutch CardioVascular Alliance (DCVA) and 4TU.Health have published its Cardiovascular (Biomedical) Technology Research Agenda.
Nomination is open for the Wiek van Gilst collaboration award!
News from Delta Plan Heart Failure: the National Heart Failure week
We are happy to announce that the National Heart Failure Week will take place from April 22 to 28, 2024, as part of the Delta Plan Heart Failure's commitment to raise public awareness of heart failure in the Netherlands.
8th DCVA-NLHI Translational Cardiovascular Research Meeting
We are pleased to inform you that the 8th DCVA NLHI Translational Cardiovascular Research Meeting will take place on Thursday 20 June and Friday 21 June 2023. We are looking forward to meeting you!
The Netherlands votes for the National Cardiovascular Agenda, as will be used in the coming ten years
We want to achieve as much as possible for cardiovascular patients with the time and resources at our disposal. That is why we make a list of important challenges in the field of cardiovascular disease. We call this list the National Cardiovascular Agenda.
Explanation animation Heart4DataAvailable in English and Dutch.
Delta Plan Heart Failure brings heart failure specialists together on online platform
Delta Plan Heart Failure launches an online platform on which heart failure specialists will work together to effectively address heart failure.
The Netherlands votes for the National Cardiovascular Agenda
At the end of October, all Dutch people – patients and their loved ones, researchers and healthcare professionals – can vote for the National Cardiovascular Agenda. The Dutch Heart Foundation is calling on as many people as possible to vote.
Putting Heart and Vascular Health on the Political Agenda
Kidney damage more effectively detected through home-based testing
Why women are not participating in clinical trials for cardiovascular disease and need to do so
The underrepresentation of women in clinical trials for cardiovascular disease treatments is a concerning issue that demands our attention. Why do fewer women participate?
Soft robotic heart research gets 11 million
A soft implantable robotic heart for people with severe heart failure. To develop it further, the Holland Hybrid Heart consortium has received 10 million euros from the National Science Agenda.
IMPRESS Factsheet Contest
Are you enthusiastic about sharing knowledge and strengthening healthcare? Would you like to participate in raising awareness of sex and gender differences in cardiovascular disease, both for patients and professionals? Then the IMPRESS Factsheet Contest is perfect for you!
Cardiovascular Animal (free) Innovations
As part of the transition towards animal-free research, the National Committee for Advisory on Animal Testing Policy has formulated a Vision for animal-free innovations for the cardiovascular field. This report represents a recommendation from one of the groups of the DCVA Leadership Program completed in 2022.
Recap of the 7th Translational Cardiovascular Research Meeting
More than three hundred passionate researchers, DCVA partners and valued stakeholders joined us for a vibrant and informative program.
Nieuwe pijlervoorzitter onderzoeksbeleid Hester den Ruijter
Deze maand start professor Hester den Ruijter, bekend om haar onderzoek naar hart- en vaatziekten bij vrouwen, als de nieuwe pijlervoorzitter onderzoeksbeleid. Wie is zij, wat zijn haar eerste indrukken en wat is ze van plan?